Jinling Pharmaceutical Company Limited (000919.SZ) SHZ

7.19

-0.07(-0.96%)

Updated at September 09 02:01PM

Currency In CNY

Valuation

Market Cap3.9B
Enterprise Value2.31B
P/E Ratio122.13
PEG Ratio1.31
Price/Sales Ratio1.34
Price/Book Ratio1.2
Enterprise/Revenue1
Enterprise/EBITDA100.45

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.01

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue3.28B
Revenue/Share5.43
Gross Profit605.68M
EBITDA203.13M
Net Income40.41M
Diluted EPS0.07

Balance Sheet

Total Cash2.56B
Total Cash/Share4.12
Total Debt187.16M
Total Debt/Equity0.05
Current Ratio3.58
Book Value Per Share7.76

Price History

52-Week Change22.02
52-Week High7.85
52-Week Low5.55
Moving Average 50 Days7.13
Moving Average 200 Days6.8

Statistics

Average Volume14.45M
Shares Outstanding621.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield1.38
Payout Ratio0.2
Last Split Factor3:2
Last Split DateJuly 10, 2006